View in EDS HTML Full Text PDF Full Text

The Korean Medication Algorithm for Major Depressive Disorder (KMA-MDD): Report of the Korean Society of Depressive and Bipolar Disorders.

Saved in:
Bibliographic Details
Title: The Korean Medication Algorithm for Major Depressive Disorder (KMA-MDD): Report of the Korean Society of Depressive and Bipolar Disorders.
Authors: Lee, Min-Soo (AUTHOR), Lim, Se-Won (AUTHOR), Cha, Ji-Hyun (AUTHOR), Chung, Sang-Keun (AUTHOR), Kim, Kwang-Su (AUTHOR), Kasper, Siegfried (AUTHOR), THE EXECUTIVE COMMITTEE FOR THE KOREAN MEDICATION ALGORITHM PROJECT FOR MAJOR DEPRESSIVE DISORDER (AUTHOR)
Source: International Journal of Psychiatry in Clinical Practice. Sep2006, Vol. 10 Issue 3, p186-194. 9p. 2 Diagrams.
Subjects: Mental depression, Affective disorders, Psychoses, Psychiatric treatment
Geographic Terms: Korea
Abstract: Objective. There are many differences in biological characteristics, clinical situations, and medical insurance systems with ethnic groups or countries. The Korean Society of Depressive and Bipolar Disorders decided to develop a Korean treatment algorithm for major depressive disorder. Methods. The Korean Medication Algorithm Project for Major Depressive Disorder (KMAP-MDD) was designed with the following principles: (1) to be an ideal algorithm, (2) to be a Korean algorithm, (3) to be a medication algorithm, (4) to be an evidence-based and formal consensus algorithm. After collecting and reviewing many literature citations and reports by evidence-based rule, we constructed a survey questionnaire for formal consensus of Korean experts. By employing panels of experts to review the evidence and survey results thoroughly, we used evidence-based algorithm development as a component of a formal consensus development process. Results. We developed two algorithms for the KMA-MDD: one for major depressive disorder without psychotic feature and the other for major depressive disorder with psychotic features. Clinical guidelines for the implementation of KMA-MDD were also developed. The KMA-MDD provides specific treatment strategies for each stage. Conclusions. The KMA-MDD is the first Korean algorithm for treatment of major depressive disorder. It is based on evidence which supports the efficacy of each treatment, and it has obtained the consensus of Korean experts. We hope that the KMA-MDD will be good practical tool for clinicians who treat major depressive disorder in Korea. [ABSTRACT FROM AUTHOR]
Copyright of International Journal of Psychiatry in Clinical Practice is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Psychology and Behavioral Sciences Collection
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: pbh
DbLabel: Psychology and Behavioral Sciences Collection
An: 22138898
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: The Korean Medication Algorithm for Major Depressive Disorder (KMA-MDD): Report of the Korean Society of Depressive and Bipolar Disorders.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Lee%2C+Min-Soo%22">Lee, Min-Soo</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lim%2C+Se-Won%22">Lim, Se-Won</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Cha%2C+Ji-Hyun%22">Cha, Ji-Hyun</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Chung%2C+Sang-Keun%22">Chung, Sang-Keun</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kim%2C+Kwang-Su%22">Kim, Kwang-Su</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kasper%2C+Siegfried%22">Kasper, Siegfried</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22THE+EXECUTIVE+COMMITTEE+FOR+THE+KOREAN+MEDICATION+ALGORITHM+PROJECT+FOR+MAJOR+DEPRESSIVE+DISORDER%22">THE EXECUTIVE COMMITTEE FOR THE KOREAN MEDICATION ALGORITHM PROJECT FOR MAJOR DEPRESSIVE DISORDER</searchLink> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22International+Journal+of+Psychiatry+in+Clinical+Practice%22">International Journal of Psychiatry in Clinical Practice</searchLink>. Sep2006, Vol. 10 Issue 3, p186-194. 9p. 2 Diagrams.
– Name: Subject
  Label: Subjects
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22Mental+depression%22">Mental depression</searchLink><br /><searchLink fieldCode="DE" term="%22Affective+disorders%22">Affective disorders</searchLink><br /><searchLink fieldCode="DE" term="%22Psychoses%22">Psychoses</searchLink><br /><searchLink fieldCode="DE" term="%22Psychiatric+treatment%22">Psychiatric treatment</searchLink>
– Name: SubjectGeographic
  Label: Geographic Terms
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22Korea%22">Korea</searchLink>
– Name: Abstract
  Label: Abstract
  Group: Ab
  Data: Objective. There are many differences in biological characteristics, clinical situations, and medical insurance systems with ethnic groups or countries. The Korean Society of Depressive and Bipolar Disorders decided to develop a Korean treatment algorithm for major depressive disorder. Methods. The Korean Medication Algorithm Project for Major Depressive Disorder (KMAP-MDD) was designed with the following principles: (1) to be an ideal algorithm, (2) to be a Korean algorithm, (3) to be a medication algorithm, (4) to be an evidence-based and formal consensus algorithm. After collecting and reviewing many literature citations and reports by evidence-based rule, we constructed a survey questionnaire for formal consensus of Korean experts. By employing panels of experts to review the evidence and survey results thoroughly, we used evidence-based algorithm development as a component of a formal consensus development process. Results. We developed two algorithms for the KMA-MDD: one for major depressive disorder without psychotic feature and the other for major depressive disorder with psychotic features. Clinical guidelines for the implementation of KMA-MDD were also developed. The KMA-MDD provides specific treatment strategies for each stage. Conclusions. The KMA-MDD is the first Korean algorithm for treatment of major depressive disorder. It is based on evidence which supports the efficacy of each treatment, and it has obtained the consensus of Korean experts. We hope that the KMA-MDD will be good practical tool for clinicians who treat major depressive disorder in Korea. [ABSTRACT FROM AUTHOR]
– Name: AbstractSuppliedCopyright
  Label:
  Group: Ab
  Data: <i>Copyright of International Journal of Psychiatry in Clinical Practice is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.)
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=22138898
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1080/13651500600633584
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 9
        StartPage: 186
    Subjects:
      – SubjectFull: Mental depression
        Type: general
      – SubjectFull: Affective disorders
        Type: general
      – SubjectFull: Psychoses
        Type: general
      – SubjectFull: Psychiatric treatment
        Type: general
      – SubjectFull: Korea
        Type: general
    Titles:
      – TitleFull: The Korean Medication Algorithm for Major Depressive Disorder (KMA-MDD): Report of the Korean Society of Depressive and Bipolar Disorders.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Lee, Min-Soo
      – PersonEntity:
          Name:
            NameFull: Lim, Se-Won
      – PersonEntity:
          Name:
            NameFull: Cha, Ji-Hyun
      – PersonEntity:
          Name:
            NameFull: Chung, Sang-Keun
      – PersonEntity:
          Name:
            NameFull: Kim, Kwang-Su
      – PersonEntity:
          Name:
            NameFull: Kasper, Siegfried
      – PersonEntity:
          Name:
            NameFull: THE EXECUTIVE COMMITTEE FOR THE KOREAN MEDICATION ALGORITHM PROJECT FOR MAJOR DEPRESSIVE DISORDER
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 09
              Text: Sep2006
              Type: published
              Y: 2006
          Identifiers:
            – Type: issn-print
              Value: 13651501
          Numbering:
            – Type: volume
              Value: 10
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: International Journal of Psychiatry in Clinical Practice
              Type: main
ResultId 1